AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval

AstraZeneca's Imfinzi (durvalumab), in combination with chemotherapy, has received approval from the US Food and Drug Administration (FDA) for treating …

Enveda Biosciences secures $55m to advance drug discovery

Enveda Biosciences has secured $55m in a Series B2 financing round to expedite its platform and advance multiple candidates to …

Novavax seeks FDA approval for updated Covid-19 vaccine

Novavax has submitted an application to the US Food and Drug Administration (FDA) seeking approval for an updated JN.1 version of …

FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia

The US Food and Drug Administration (FDA) has approved Amgen’s BLINCYTO (blinatumomab) for CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukaemia (B-ALL) …

Daxdilimab by Amgen for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE): Likelihood of Approval

Daxdilimab is under clinical development by Amgen and currently in Phase II for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid …